DE69408299T2 - Phospholipase c inhibitierendes peptid - Google Patents

Phospholipase c inhibitierendes peptid

Info

Publication number
DE69408299T2
DE69408299T2 DE69408299T DE69408299T DE69408299T2 DE 69408299 T2 DE69408299 T2 DE 69408299T2 DE 69408299 T DE69408299 T DE 69408299T DE 69408299 T DE69408299 T DE 69408299T DE 69408299 T2 DE69408299 T2 DE 69408299T2
Authority
DE
Germany
Prior art keywords
leu
val
single bond
phospholipase
inhibiting peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69408299T
Other languages
English (en)
Other versions
DE69408299D1 (de
Inventor
Motoo Yamasaki
Genkichi Ishikawa
Yoshimi Honma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE69408299D1 publication Critical patent/DE69408299D1/de
Application granted granted Critical
Publication of DE69408299T2 publication Critical patent/DE69408299T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DE69408299T 1993-09-10 1994-09-08 Phospholipase c inhibitierendes peptid Expired - Fee Related DE69408299T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22539793 1993-09-10
PCT/JP1994/001486 WO1995007293A1 (fr) 1993-09-10 1994-09-08 Peptide inhibant la phospholipase c

Publications (2)

Publication Number Publication Date
DE69408299D1 DE69408299D1 (de) 1998-03-05
DE69408299T2 true DE69408299T2 (de) 1998-08-20

Family

ID=16828725

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69408299T Expired - Fee Related DE69408299T2 (de) 1993-09-10 1994-09-08 Phospholipase c inhibitierendes peptid

Country Status (7)

Country Link
US (1) US5847074A (de)
EP (1) EP0672679B1 (de)
AT (1) ATE162850T1 (de)
CA (1) CA2149038C (de)
DE (1) DE69408299T2 (de)
ES (1) ES2114220T3 (de)
WO (1) WO1995007293A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677420A (en) * 1995-03-10 1997-10-14 Kyowa Hakko Kogyo Co., Ltd. Phospholipase c-inhibiting peptides
EP0760376A4 (de) * 1995-03-10 1999-09-01 Kyowa Hakko Kogyo Kk Die phospholipase c inhibierende peptide
ES2321584T3 (es) * 2000-07-17 2009-06-09 Astellas Pharma Inc. Fk228 reducido y su uso.
US20020107193A1 (en) * 2000-11-09 2002-08-08 Glazner Gordon W. Therapeutic uses for IP3 receptor-mediated calcium channel modulators
US6527912B2 (en) 2001-03-30 2003-03-04 Lam Research Corporation Stacked RF excitation coil for inductive plasma processor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2102609A1 (en) * 1992-03-11 1993-09-12 Hiromitsu Saito Phospholipase c-inhibiting peptides

Also Published As

Publication number Publication date
ATE162850T1 (de) 1998-02-15
ES2114220T3 (es) 1998-05-16
DE69408299D1 (de) 1998-03-05
US5847074A (en) 1998-12-08
EP0672679A1 (de) 1995-09-20
WO1995007293A1 (fr) 1995-03-16
EP0672679A4 (de) 1995-12-06
CA2149038A1 (en) 1995-03-16
CA2149038C (en) 2000-06-13
EP0672679B1 (de) 1998-01-28

Similar Documents

Publication Publication Date Title
DE69638025D1 (de) Parathyroidhormon Analoge
DK0590006T3 (da) Syntetiske pulmonære surfaktantpeptider
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
IT1270882B (it) Oligopeptidi ad attivita' fungicida
IE840474L (en) Peptide analogues
AUPP051497A0 (en) Antimicrobial peptides
DE69417252T2 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
IL105347A0 (en) Multiple sclerosis t-cell receptor
EP0334244A3 (de) Peptide-Antagonisten von Bradykinin
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
TR200101492T2 (tr) IGF-I ve II 'yi engelleyen GH-RH'nın antagonistik analogları
ATE162850T1 (de) Phospholipase c inhibitierendes peptid
CA2020663A1 (en) Substitution analogues of magainin peptides
EP0298732A3 (en) Therapeutic somatostatin analogues
AU9057791A (en) Tetrapeptide derivatives and analogues
DE69417872T2 (de) Inhibitor peptid spezifisch für cathepsin-l
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
EP0296374A3 (en) Glycosylated aminoacids and peptides
SE8901278D0 (sv) Peptide derivatives
AU635669B2 (en) Peptide with activity of inhibiting phospholipase a2 originating in inflamed part

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee